Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to confirm a safe dose of AS1404, to be given with docetaxel,
and to see whether adding AS1404 and docetaxel together improves the outcome of the
treatment, when compared to docetaxel alone.